• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服单剂量西他列汀餐前给药不会影响正常受试者循环中的 ghrelin 和 gastrin 水平。

Preprandial single oral dose of sitagliptin does not affect circulating ghrelin and gastrin levels in normal subjects.

机构信息

Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan, ROC.

出版信息

Pharmacology. 2010;85(3):131-5. doi: 10.1159/000280583. Epub 2010 Feb 9.

DOI:10.1159/000280583
PMID:20145424
Abstract

AIMS

To determine the effect of an oral dose of sitagliptin on the secretion of ghrelin and gastrin hormones.

METHODS

Ten healthy volunteers were recruited in this study. A baseline blood sample was drawn before oral dosing with a 100-mg tablet of sitagliptin. Two blood samples were obtained 0.5 and 1 h after dosing. Three additional postprandial blood samples were drawn at 0.5, 1, and 2 h. Radioimmunoassay was used for determining hormonal levels. A Student's t test, Pearson correlation analysis, and multivariate approach to repeated-measures analysis of variance were used for statistics.

RESULTS

After sitagliptin dosing, but before the meal, there was no significant change in circulating ghrelin, gastrin, insulin, and glucose levels. Only after meal loading was there a progressive and persistent decline in ghrelin levels until the end of the study, while a rapid and temporary rise in gastrin, insulin, and glucose levels at 0.5 h was observed. The levels of gastrin, insulin, and glucose then declined progressively.

CONCLUSIONS

Preprandial oral dose of sitagliptin does not affect circulating ghrelin, gastrin, insulin, and glucose concentrations in normal subjects. Decreased ghrelin and increased gastrin and insulin levels occurred only after meal loading. These results support the theory that sitagliptin might not cause appetite-enhanced body weight gain and insulin-induced hypoglycemia.

摘要

目的

确定口服西他列汀对胃饥饿素和胃泌素激素分泌的影响。

方法

本研究招募了 10 名健康志愿者。在口服 100mg 西他列汀片之前,抽取基线血样。给药后 0.5 和 1 小时采集 2 份血样。给药后 0.5、1 和 2 小时还采集了 3 份餐后血样。采用放射免疫法测定激素水平。采用学生 t 检验、皮尔逊相关分析和重复测量方差的多变量方法进行统计学分析。

结果

西他列汀给药后,但在进餐前,循环中胃饥饿素、胃泌素、胰岛素和血糖水平没有显著变化。只有在进食负荷后,胃饥饿素水平才会逐渐持续下降,直至研究结束,而胃泌素、胰岛素和血糖水平在 0.5 小时会迅速暂时升高。然后,胃泌素、胰岛素和血糖水平逐渐下降。

结论

正常受试者餐前口服西他列汀不会影响循环中胃饥饿素、胃泌素、胰岛素和血糖浓度。只有在进食负荷后才会出现胃饥饿素降低和胃泌素和胰岛素水平升高。这些结果支持西他列汀可能不会引起食欲增强体重增加和胰岛素引起的低血糖的理论。

相似文献

1
Preprandial single oral dose of sitagliptin does not affect circulating ghrelin and gastrin levels in normal subjects.口服单剂量西他列汀餐前给药不会影响正常受试者循环中的 ghrelin 和 gastrin 水平。
Pharmacology. 2010;85(3):131-5. doi: 10.1159/000280583. Epub 2010 Feb 9.
2
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.二肽基肽酶-IV抑制剂西他列汀多次口服给药的药代动力学和药效学特性:一项在健康男性志愿者中进行的双盲、随机、安慰剂对照研究
Clin Ther. 2006 Jan;28(1):55-72. doi: 10.1016/j.clinthera.2006.01.015.
3
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.二肽基肽酶-4抑制剂西他列汀对2型糖尿病患者β细胞功能的影响:基于模型的方法
Diabetes Obes Metab. 2008 Dec;10(12):1212-20. doi: 10.1111/j.1463-1326.2008.00887.x. Epub 2008 May 12.
4
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.二肽基肽酶IV抑制剂西他列汀在健康受试者中的药代动力学和药效学:两项单次口服剂量随机、双盲、安慰剂对照研究的结果
Clin Pharmacol Ther. 2005 Dec;78(6):675-88. doi: 10.1016/j.clpt.2005.09.002.
5
Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement.西他列汀每日100毫克对二肽基肽酶-4(DPP-4)的抑制作用及化合物特异性血糖改善情况。
Curr Med Res Opin. 2009 Oct;25(10):2507-14. doi: 10.1185/03007990903209514.
6
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.二肽基肽酶-4抑制剂西他列汀在仅使用格列美脲或使用格列美脲与二甲双胍血糖控制不佳的2型糖尿病患者中的疗效和安全性。
Diabetes Obes Metab. 2007 Sep;9(5):733-45. doi: 10.1111/j.1463-1326.2007.00744.x. Epub 2007 Jun 26.
7
Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan.肝硬化和门静脉高压患者在未服用及口服褪黑素或色氨酸情况下基础及餐后血浆褪黑素、胃泌素、胃饥饿素、瘦素和胰岛素的变化。
J Pineal Res. 2009 May;46(4):408-14. doi: 10.1111/j.1600-079X.2009.00677.x. Epub 2009 Apr 9.
8
Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.在2型糖尿病患者中,将二肽基肽酶-4抑制剂西他列汀添加至二甲双胍对24小时血糖控制及β细胞功能的影响。
Diabetes Obes Metab. 2007 Mar;9(2):186-93. doi: 10.1111/j.1463-1326.2006.00691.x.
9
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.在2型糖尿病患者中,将二肽基肽酶-4抑制剂西他列汀添加至正在进行的吡格列酮治疗中的疗效和安全性:一项为期24周的多中心、随机、双盲、安慰剂对照、平行组研究。
Clin Ther. 2006 Oct;28(10):1556-68. doi: 10.1016/j.clinthera.2006.10.007.
10
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.患有中度和重度肥胖及代谢综合征的女性中,PYY、胃饥饿素、胆囊收缩素、胃泌素和胰岛素的基础及餐后血浆水平。
J Physiol Pharmacol. 2007 Mar;58 Suppl 1:13-35.

引用本文的文献

1
Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study.西他列汀治疗效果降低的相关因素:JAMP研究的亚组分析
Diabetol Int. 2017 Dec 16;9(3):158-167. doi: 10.1007/s13340-017-0340-0. eCollection 2018 Jul.
2
Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.二肽基肽酶-4抑制剂改善2型糖尿病患者的血糖调节:关注α细胞和β细胞功能及脂质代谢。
Diabetologia. 2016 May;59(5):907-17. doi: 10.1007/s00125-016-3899-2. Epub 2016 Feb 19.
3
Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study.
米格列醇、阿卡波糖和西他列汀对2型糖尿病患者血浆胰岛素和肠肽的影响:一项交叉研究。
Diabetes Ther. 2015 Jun;6(2):187-96. doi: 10.1007/s13300-015-0113-3. Epub 2015 Jun 9.
4
Influence of a long-term high-fat diet on ghrelin secretion and ghrelin-induced food intake in rats.长期高脂饮食对大鼠胃饥饿素分泌及胃饥饿素诱导的食物摄入量的影响。
Regul Pept. 2012 Jan 10;173(1-3):60-3. doi: 10.1016/j.regpep.2011.09.006. Epub 2011 Oct 3.